Feasibility study for a randomised controlled trial evaluating the use of absorbable mesh, polydioxanone and polyglactin sutures for anterior and posterior vaginal wall prolapse repairs

ISRCTN ISRCTN86144697
DOI https://doi.org/10.1186/ISRCTN86144697
Secondary identifying numbers Version 1 09 11 2004
Submission date
21/08/2005
Registration date
15/09/2005
Last edited
13/10/2009
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Sabeena Allahdin
Scientific

26 Springdale Road Bieldside
Aberdeen
AB15 9FA
United Kingdom

Study information

Study designRandomised controlled 2x2 factorial design trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study acronymIMPRESS: Is it Mesh or Suture for PRolapsE Surgery Success
Study objectivesThe use of absorbable mesh or not for primary prolapse surgery.
The choice of absorbable suture for primary prolapse surgery.

What will the work achieve?
We aim to answer the following questions:
1. Is absorbable mesh (polyglactin) effective in treatment of primary prolapse surgery?
2. Is polydioxanone (PDS) or polyglactin (Vicryl) a better suture material to use for primary prolapse surgery?
3. What are the effects of mesh and different suture material on short-term and long-term morbidity, recurrence of prolapse symptoms, and quality of life?
4. Is it feasible to mount a randomised controlled trial to answer these questions?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedProlapse
InterventionA randomised controlled trial using a 2x2 factorial design of absorbable mesh compared with no mesh, and two types of sutures for anterior or posterior pelvic organ prolapse repair.
Intervention typeOther
Primary outcome measureRecurrence of (or failure to cure) prolapse symptoms. One of the aims of the feasibility study is to test how best to assess these outcome measures and their inclusiveness.
Secondary outcome measures1. Immediate and late postoperative morbidity
2. Recurrence of prolapse
3. Quality of life
4. Satisfaction with surgery and economic outcomes
Overall study start date15/05/2005
Completion date31/08/2005

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participants70
Key inclusion criteriaAll women admitted for primary pelvic organ prolapse surgery with grade 2 or more pelvic organ prolapse who are willing to participate in the trial. Women undergoing concurrent hysterectomy or continence procedures will also be eligible.
Key exclusion criteriaWomen with less than a grade 2 prolapse, those unwilling or unable to participate in the trial.
Date of first enrolment15/05/2005
Date of final enrolment31/08/2005

Locations

Countries of recruitment

  • Scotland
  • United Kingdom

Study participating centre

26 Springdale Road Bieldside
Aberdeen
AB15 9FA
United Kingdom

Sponsor information

University of Aberdeen (UK)
University/education

Medical School
R&D Department
Foresterhill Annexe
Foresterhill Road
Aberdeen
AB25 2ZB
Scotland
United Kingdom

ROR logo "ROR" https://ror.org/016476m91

Funders

Funder type

Hospital/treatment centre

Small departmental research fund

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/05/2008 Yes No